Urinary OH-PAHs | Lung function parameters | Estimated changes (95% CI) by continuous OH-PAHs | Estimated changes in ml (95% CI) by quartile of OH-PAHs | P value for trenda | |||
---|---|---|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | ||||
ƩOH-PAHs |  |  | < 24.63 | 24.63–36.12 | 36.12–54.86 | ≥54.86 |  |
FEV1 | −21.52 (−40.46, −2.58) | 0 (referent) | −39.63 (−76.83, −2.43) | −11.74 (− 49.41, 25.94) | −65.59 (− 103.42, − 27.77) | 0.0057 | |
FVC | − 18.91 (− 41.95, 4.14) | 0 (referent) | − 34.69 (−79.99, 10.61) | 2.51 (−43.39, 48.42) | −57.89 (− 103.95, − 11.83) | 0.0651 | |
FEV1% | −0.17 (−0.57, 0.23) | 0 (referent) | −0.49 (− 1.28, 0.29) | − 0.53 (− 1.32, 0.27) | − 0.57 (− 1.37, 0.23) | 0.1791 | |
ƩHMW OH-PAH |  |  | < 1.99 | 1.99–3.21 | 3.21–5.41 | ≥5.41 |  |
FEV1 | −20.76 (− 37.69, − 3.83) | 0 (referent) | −25.06 (−61.93, 11.81) | − 31.01 (− 68.12 6.11) | −54.55 (−91.82, − 17.28) | 0.0049 | |
FVC | − 21.59 (−42.18, − 1.00) | 0 (referent) | − 9.94 (− 54.77, 34.89) | −31.06 (− 76.20, 14.08) | −54.59 (− 99.91, − 9.27) | 0.0116 | |
FEV1% | − 0.07 (− 0.43, 0.29) | 0 (referent) | − 0.58 (− 1.36, 0.19) | −0.36 (− 1.15, 0.42) | −0.30 (− 1.08, 0.49) | 0.5963 | |
ƩLMW OH-PAHs |  |  | < 21.68 | 21.68–32.24 | 32.24–49.23 | ≥49.23 |  |
FEV1 | −19.85 (− 38.44, − 1.26) | 0 (referent) | −39.60 (− 76.90, − 12.31) | −15.47 (−53.18, 22.24) | − 61.75 (−99.81, − 23.70) | 0.0090 | |
FVC | −16.34 (− 38.60, 6.27) | 0 (referent) | −37.59 (− 83.01, 7.82) | −3.39 (− 49.34, 42.56) | −50.65 (− 97.01, −4.30) | 0.1166 | |
FEV1% | − 0.19 (− 0.59, 0.20) | 0 (referent) | − 0.36 (− 1.15, 0.43) | −0.42 (− 1.22, 0.38) | −0.65 (− 1.46, 0.15) | 0.1205 |